6/17
08:48 pm
spry
Form SC 13D/A ARS Pharmaceuticals, Filed by: Pratik Shah Living Trust dated June 15, 2011
Medium
Report
Form SC 13D/A ARS Pharmaceuticals, Filed by: Pratik Shah Living Trust dated June 15, 2011
6/17
06:39 pm
spry
Form 4 ARS Pharmaceuticals, For: Jun 13 Filed by: Shah Pratik
Medium
Report
Form 4 ARS Pharmaceuticals, For: Jun 13 Filed by: Shah Pratik
6/13
04:31 pm
spry
Form 4 ARS Pharmaceuticals, For: Jun 11 Filed by: Tanimoto Sarina
Medium
Report
Form 4 ARS Pharmaceuticals, For: Jun 11 Filed by: Tanimoto Sarina
6/13
04:31 pm
spry
Form 4 ARS Pharmaceuticals, For: Jun 11 Filed by: Lowenthal Richard E
Medium
Report
Form 4 ARS Pharmaceuticals, For: Jun 11 Filed by: Lowenthal Richard E
6/11
07:19 pm
spry
Form SC 13D/A ARS Pharmaceuticals, Filed by: Pratik Shah Living Trust dated June 15, 2011
Medium
Report
Form SC 13D/A ARS Pharmaceuticals, Filed by: Pratik Shah Living Trust dated June 15, 2011
6/11
11:36 am
spry
Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
Low
Report
Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
6/7
09:12 pm
spry
Form 4 ARS Pharmaceuticals, For: Jun 07 Filed by: Shah Pratik
Medium
Report
Form 4 ARS Pharmaceuticals, For: Jun 07 Filed by: Shah Pratik
6/7
09:09 pm
spry
Form 4/A ARS Pharmaceuticals, For: Jun 04 Filed by: Shah Pratik
Medium
Report
Form 4/A ARS Pharmaceuticals, For: Jun 04 Filed by: Shah Pratik
6/6
04:33 pm
spry
Form 4 ARS Pharmaceuticals, For: Jun 04 Filed by: Shah Pratik
Low
Report
Form 4 ARS Pharmaceuticals, For: Jun 04 Filed by: Shah Pratik
5/16
07:53 pm
spry
Form 4 ARS Pharmaceuticals, For: May 14 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: May 14 Filed by: Tanimoto Sarina
5/16
07:52 pm
spry
Form 4 ARS Pharmaceuticals, For: May 14 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: May 14 Filed by: Lowenthal Richard E
5/10
07:02 am
spry
Form 8-K ARS Pharmaceuticals, For: May 10
Medium
Report
Form 8-K ARS Pharmaceuticals, For: May 10
5/9
06:59 pm
spry
Form 4 ARS Pharmaceuticals, For: May 07 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: May 07 Filed by: Tanimoto Sarina
5/9
06:57 pm
spry
Form 4 ARS Pharmaceuticals, For: May 07 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: May 07 Filed by: Lowenthal Richard E
5/9
04:14 pm
spry
Form 10-Q ARS Pharmaceuticals, For: Mar 31
Low
Report
Form 10-Q ARS Pharmaceuticals, For: Mar 31
5/9
04:10 pm
spry
Form 8-K ARS Pharmaceuticals, For: May 09
Low
Report
Form 8-K ARS Pharmaceuticals, For: May 09
4/26
04:06 pm
spry
Form ARS ARS Pharmaceuticals, For: Dec 31
Low
Report
Form ARS ARS Pharmaceuticals, For: Dec 31
4/26
04:05 pm
spry
Form DEFA14A ARS Pharmaceuticals,
Low
Report
Form DEFA14A ARS Pharmaceuticals,
4/26
04:03 pm
spry
Form DEF 14A ARS Pharmaceuticals, For: Jun 20
Low
Report
Form DEF 14A ARS Pharmaceuticals, For: Jun 20
4/24
06:19 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Tanimoto Sarina
4/24
06:18 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Lowenthal Richard E
4/22
07:23 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Tanimoto Sarina
4/22
07:22 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Lowenthal Richard E
4/17
06:43 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Tanimoto Sarina
Medium
Report
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Tanimoto Sarina
4/17
06:41 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Lowenthal Richard E
Medium
Report
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Lowenthal Richard E